Dose-ranging Study of a Single Administration of T-cell Add-back Depleted of Host Alloreactive Cells in Patients Undergoing a Peripheral Blood Stem Cell Transplant From a Related, Haploidentical Donor

NCT00993486 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

19

Enrollment

INDUSTRY

Sponsor class

Conditions

Hematologic Diseases
Hematologic Malignancies

Interventions

BIOLOGICAL: Donor lymphocyte preparation depleted of functional host alloreactive T-cells (ATIR)

Sponsor

Kiadis Pharma